Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) — Stella

Home/Schizophrenia/

View on ClinicalTrials.gov

Recruiting

Back to Schizophrenia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

The University of Texas Health Science Center, Houston, Houston, Texas

Key details

Sponsor

The University of Texas Health Science Center, Houston

Enrollment target

~120 participants

Started

June 2025

Primary completion

May 2029

Age range

18 Years – 60 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.